Class information for:
Level 1: RECEPTOR OCCUPANCY THEORY//DIACETOLOL//TERNARY COMPLEX MODEL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
7798 1248 25.3 33%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
895 10656 CARVEDILOL//NEBIVOLOL//BETA BLOCKERS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 RECEPTOR OCCUPANCY THEORY Author keyword 3 60% 0% 3
2 DIACETOLOL Author keyword 1 50% 0% 2
3 TERNARY COMPLEX MODEL Author keyword 1 27% 0% 3
4 BETA ADRENERGIC RECEPTOR BLOCKING AGENT Author keyword 1 50% 0% 1
5 BINDING OCCUPANCY Author keyword 1 50% 0% 1
6 CARBON TETRACHLORIDE INDUCED HEPATIC FAILURE Author keyword 1 50% 0% 1
7 CARDIAC AUTONOMIC NERVOUS FUNCTION Author keyword 1 50% 0% 1
8 CAS 525 66 6 Author keyword 1 50% 0% 1
9 CHEM SCI ANALYT Address 1 50% 0% 1
10 DOSAGE REGIMEN DESIGN Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 RECEPTOR OCCUPANCY THEORY 3 60% 0% 3 Search RECEPTOR+OCCUPANCY+THEORY Search RECEPTOR+OCCUPANCY+THEORY
2 DIACETOLOL 1 50% 0% 2 Search DIACETOLOL Search DIACETOLOL
3 TERNARY COMPLEX MODEL 1 27% 0% 3 Search TERNARY+COMPLEX+MODEL Search TERNARY+COMPLEX+MODEL
4 BETA ADRENERGIC RECEPTOR BLOCKING AGENT 1 50% 0% 1 Search BETA+ADRENERGIC+RECEPTOR+BLOCKING+AGENT Search BETA+ADRENERGIC+RECEPTOR+BLOCKING+AGENT
5 BINDING OCCUPANCY 1 50% 0% 1 Search BINDING+OCCUPANCY Search BINDING+OCCUPANCY
6 CARBON TETRACHLORIDE INDUCED HEPATIC FAILURE 1 50% 0% 1 Search CARBON+TETRACHLORIDE+INDUCED+HEPATIC+FAILURE Search CARBON+TETRACHLORIDE+INDUCED+HEPATIC+FAILURE
7 CARDIAC AUTONOMIC NERVOUS FUNCTION 1 50% 0% 1 Search CARDIAC+AUTONOMIC+NERVOUS+FUNCTION Search CARDIAC+AUTONOMIC+NERVOUS+FUNCTION
8 CAS 525 66 6 1 50% 0% 1 Search CAS+525+66+6 Search CAS+525+66+6
9 DOSAGE REGIMEN DESIGN 1 50% 0% 1 Search DOSAGE+REGIMEN+DESIGN Search DOSAGE+REGIMEN+DESIGN
10 DRUG FORM 1 50% 0% 1 Search DRUG+FORM Search DRUG+FORM

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 DIACETOLOL 6 80% 0% 4
2 ACETYL METABOLITE 3 100% 0% 3
3 ANTAGONIST METOPROLOL 2 44% 0% 4
4 CR ZOK 2 36% 0% 5
5 ATENOLOL CHLORTHALIDONE COMBINATION 1 100% 0% 2
6 CONVENTIONAL METOPROLOL 1 100% 0% 2
7 CR ZOK FORMULATION 1 100% 0% 2
8 SLOW RELEASE METOPROLOL 1 50% 0% 2
9 LONG ACTING PROPRANOLOL 1 29% 0% 4
10 SUBJECTIVE ASSESSMENTS 1 19% 0% 5

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
NEUROPSYCHOLOGICAL SIDE-EFFECTS OF BETA-BLOCKERS 1989 61 43 56%
BETAXOLOL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN HYPERTENSION 1986 57 22 82%
BETA-BLOCKERS AND CENTRAL-NERVOUS-SYSTEM SIDE-EFFECTS 1990 89 146 45%
CONTROLLED RELEASE METOPROLOL FORMULATIONS - A REVIEW OF THEIR PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND ISCHEMIC-HEART-DISEASE 1992 29 118 52%
Treatment with beta-blockers - the value of an even plasma concentration over 24 h 1997 9 36 53%
Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension 2010 7 57 32%
Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas 2015 5 59 22%
beta-adrenergic blockers in systemic hypertension - Pharmacokinetic considerations related to the current guidelines 2002 27 29 34%
METOPROLOL - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY, IN HYPERTENSION, ISCHEMIC-HEART-DISEASE AND RELATED CARDIOVASCULAR DISORDERS 1986 79 264 31%
CONTROLLED RELEASE METOPROLOL - CLINICAL PHARMACOKINETIC AND THERAPEUTIC IMPLICATIONS 1991 25 51 53%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CHEM SCI ANALYT 1 50% 0.1% 1
2 AMBULANTE SPEZIALMED 0 25% 0.1% 1
3 MED PHARMCEUT SCI 0 20% 0.1% 1
4 I EM HEART DIS 0 17% 0.1% 1
5 CENT HOSP MED 1 0 13% 0.1% 1
6 EXCITABLE MEMBRANES 0 13% 0.1% 1
7 U80 0 13% 0.1% 1
8 VA ALMAZOV CARDIOL 0 11% 0.1% 1
9 MEDICO PHARMACEUT SCI 0 10% 0.1% 1
10 54 SHOGOIN KAWARA CHOSAKYO KU 0 100% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000270875 CELIPROLOL//BEVANTOLOL//PERINDOPRIL THERAPEUTIC USE
2 0.0000183991 BISOPROLOL//CARDIOSELECTIVE BETA BLOCKERS//CARDIOSELECTIVE
3 0.0000180855 ANTIHYPERTENSIVE PHARMACOTHERAPY//BETA1 BLOCKADE//CARDIOVASC P REHABIL UNIT
4 0.0000165181 MED HOSP PHARM YAHATANISHI KU//4 HYDROXYPROPRANOLOL//PROPRANOLOL METABOLISM
5 0.0000155899 AMOSULALOL//TERTATOLOL//DILEVALOL
6 0.0000127556 ATENOLOL//ALPHA HYDROXYMETOPROLOL//ACEBUTOLOL HYDROCHLORIDE
7 0.0000126580 DRUG INDUCED DEPRESSION//DEPRESSIVE DISORDER CHEMICALLY INDUCED//CORPS MED PSYCHOL
8 0.0000118526 BOPINDOLOL//NIPRADILOL//H 3 CGP12177
9 0.0000116598 COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER
10 0.0000112347 MINICHAL//ANTIHYPERTENSIVE DRUG CLASSES//ANTIHYPERTENSIVE REGIMENS